#VisualAbstract: Casirivimab and imdevimab reduced mortality in seronegative patients with COVID-19
1. All-cause mortality at 28 days was significantly higher in the usual care group compared to the...
Read More
studygraphics
#VisualAbstract: Capecitabine in addition to best supportive care improves progression-free survival in metastatic nasopharyngeal carcinoma
Click to read this study in JAMA Oncology.
Read More
#VisualAbstract: Cutaneous squamous cell carcinoma with satellitosis or in-transit metastasis shows similar survival to node-positive disease
Click to read this study in JAMA Dermatology.
Read More
#VisualAbstract: Mobile stroke units associated with better outcomes for acute ischemic stroke management
Compared with usual care, mobile stroke unit deployment was associated with a significant increase...
Read More
#VisualAbstract: Abiraterone acetate improves survival in high-risk non-metastatic prostate cancer compared to control
Abiraterone acetate plus standard treatment significantly increased length of metastasis-free...
Read More
#VisualAbstract: Time-of-infusion with immunotherapy may impact survival outcomes for patients with advanced melanoma
Click to read this study in Lancet Oncology.
Read More
#VisualAbstract: Fulvestrant plus cyclin-dependent kinase 4/6 inhibitors improves survival in HR⁺, HER2- metastatic breast cancer
Click to read this study in Lancet Oncology.
Read More
#VisualAbstract: Effectiveness of sacubitril-valsartan in post-myocardial infarction management compared to ramipril
In patients with acute myocardial infarction, Sacubitril-valsartan was not associated with a...
Read More
#VisualAbstract: Ianalumab shows a dose-related improvement in disease activity in Sjögren’s syndrome without serious adverse events
There was a dose-related decrease in disease activity from baseline to 24-weeks for patients on ianalumab compared to placebo. There were no serious adverse events from the maximum dose of 300 mg ianalumab, and it was well tolerated by trial participants. Evidence Rating Level: 1 (Excellent) Study Rundown: Sjögren’s syndrome is an autoimmune disorder which is currently […]
Read More
#VisualAbstract: Induction chemotherapy with concurrent chemoradiotherapy may improve survival in intermediate-risk pediatric patients with nasopharyngeal carcinoma
Click to read this study in the European Journal of Cancer.
Read More
#VisualAbstract: Convalescent Plasma Ineffective at Improving Clinical Outcomes or Mortality in Non-Ventilated Patients With COVID-19
This meta-analysis found that treatment with COVID-19 convalescent plasma (CCP), compared to control group treatment, did not improve clinical outcomes, as measured by the World Health Organization clinical outcome score, or mortality. There was an improvement in the mortality and clinical outcomes for participants treated with CCP who had a baseline WHO score of 4 […]
Read More
#VisualAbstract: Addition of radiotherapy to anti-PD-1 therapy does not improve survival in advanced mucosal melanoma
Click to read this study in the European Journal of Cancer.
Read More